Results 11 to 20 of about 66,181 (261)

Granzymes at a glance [PDF]

open access: yesJournal of Cell Science, 2006
Defence against virally infected and malignant cells depends on the action of cytotoxic T lymphocytes and natural killer cells ([Barry and Bleackley, 2002][1]; [Russell and Ley, 2002][2]). Although these use several mechanisms to eliminate target cells, the principal event is secretion of ...
Bots, Michael, Medema, Jan Paul
openaire   +3 more sources

Granzyme B Attenuates Bacterial Virulence by Targeting Secreted Factors [PDF]

open access: yes, 2020
Pathogenic bacteria secrete virulence factors that interact with the human host to establish infections. The human immune system evolved multiple mechanisms to fight bacterial invaders, including immune proteases that were demonstrated to contribute ...
Blanchard M.   +31 more
core   +2 more sources

Maltose-binding protein enhances secretion of recombinant human granzyme B accompanied by in vivo processing of a precursor MBP fusion protein [PDF]

open access: yes, 2010
Background: The apoptosis-inducing serine protease granzyme B (GrB) is an important factor contributing to lysis of target cells by cytotoxic lymphocytes.
Wels, Winfried   +14 more
core   +1 more source

Mcl-1 is a key regulator of apoptosis resistance in Chlamydia trachomatis-infected cells [PDF]

open access: yes, 2008
Chlamydia are obligate intracellular bacteria that cause variety of human diseases. Host cells infected with Chlamydia are protected against many different apoptotic stimuli.
Manu Sharma   +32 more
core   +2 more sources

Neuroinflammation by cytotoxic T-lymphocytes impairs retrograde axonal transport in an oligodendrocyte mutant mouse [PDF]

open access: yes, 2012
Mice overexpressing proteolipid protein (PLP) develop a leukodystrophy-like disease involving cytotoxic, CD8+ T-lymphocytes. Here we show that these cytotoxic T-lymphocytes perturb retrograde axonal transport.
Groh Janos   +47 more
core   +1 more source

GZMA (granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3)) [PDF]

open access: yes, 2012
Review on GZMA (granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3)), with data on DNA, on the protein encoded, and where the gene is ...
Catalan, E   +2 more
core   +1 more source

Granzymes in cancer and immunity [PDF]

open access: yesCell Death & Differentiation, 2010
Cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells are indispensable factors in the body's ongoing defence against viral infection and tumor development. CTL/NK cells recognize and kill infected or aberrant target cells by two major pathways: either through introduction of a battery of proteases - called granzymes - to the target cell cytosol,
S P, Cullen, M, Brunet, S J, Martin
openaire   +2 more sources

A quarter century of granzymes [PDF]

open access: yesCell Death & Differentiation, 2011
Granzymes (Grs) were discovered just over a quarter century ago. They are produced by cytotoxic T cells and natural killer cells and are released upon interaction with target cells. Intensive biochemical, genetic, and biological studies have been performed in order to study their roles in immunity and inflammation.
C L, Ewen, K P, Kane, R C, Bleackley
openaire   +2 more sources

Control of granzymes by serpins [PDF]

open access: yesCell Death & Differentiation, 2009
Although proteolysis mediated by granzymes has an important role in the immune response to infection or tumours, unrestrained granzyme activity may damage normal cells. In this review, we discuss the role of serpins within the immune system, as specific regulators of granzymes. The well-characterised human granzyme B-SERPINB9 interaction highlights the
D, Kaiserman, P I, Bird
openaire   +2 more sources

Granzymes—Their Role in Colorectal Cancer

open access: yesInternational Journal of Molecular Sciences, 2022
Colorectal cancer (CRC) is among the most common malignancies worldwide. CRC is considered a heterogeneous disease due to various clinical symptoms, biological behaviours, and a variety of mutations. A number of studies demonstrate that as many as 50% of CRC patients have distant metastases at the time of diagnosis.
Sara Pączek   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy